{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:08:44Z","timestamp":1781658524786,"version":"3.54.5"},"reference-count":66,"publisher":"American Society for Microbiology","issue":"18","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OV5-170710"],"award-info":[{"award-number":["OV5-170710"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VS1-175520"],"award-info":[{"award-number":["VS1-175520"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","award":["OV5-170710"],"award-info":[{"award-number":["OV5-170710"]}],"id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2022,9,28]]},"abstract":"<jats:p>Given that both COVID-19 and influenza are preferably transmitted through respiratory droplets during the same seasons, it is highly advantageous to develop a bivalent vaccine that could simultaneously protect against both COVID-19 and influenza. In this study, we generated the attenuated replicating recombinant vesicular stomatitis virus (rVSV)-based vaccine candidates that target both spike protein of SARS-Cov-2 Delta variant and the conserved influenza M2 domain.<\/jats:p>","DOI":"10.1128\/jvi.01337-22","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T13:01:12Z","timestamp":1662555672000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":25,"title":["A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection"],"prefix":"10.1128","volume":"96","author":[{"given":"Zhujun","family":"Ao","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Human Retrovirology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie J.","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Human Retrovirology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus A.","family":"Olukitibi","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Human Retrovirology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Warner","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vendramelli","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thang","family":"Truong","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Meilleur","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kung","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Fowke","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwyn","family":"Kobasa","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-1309","authenticated-orcid":true,"given":"Xiaojian","family":"Yao","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Human Retrovirology, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01230-y"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00592-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09929-7"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00518"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.04.040"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321013"},{"key":"e_1_3_2_8_2","first-page":"1104","article-title":"SARS-CoV-2 B.1.617.2 (Delta) variant COVID-19 outbreak associated with a gymnastics facility\u2014Oklahoma, April\u2013May 2021","volume":"70","author":"Dougherty K","year":"2021","unstructured":"Dougherty K, Mannell M, Naqvi O, Matson D, Stone J. 2021. SARS-CoV-2 B.1.617.2 (Delta) variant COVID-19 outbreak associated with a gymnastics facility\u2014Oklahoma, April\u2013May 2021. Morbidity and Mortality Wkly Report 70:1104.","journal-title":"Morbidity and Mortality Wkly Report"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2022.01.001"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.046"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28089-y"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.211248"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104759"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3750-8"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00343"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.020421"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12383"},{"key":"e_1_3_2_18_2","unstructured":"Centers for Disease Control and Prevention. 2021. Past seasons vaccine effectiveness estimates. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/flu\/vaccines-work\/past-seasons-estimates.html."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.937192"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29401-x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00482-2"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.087"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3920"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1473698"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3723-3732.1999"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.07.018"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00352-1"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20228-7"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788235"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03379-21"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010092"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02368-20"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.06.046"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251649"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.5.2239-2246.2000"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","unstructured":"Olukitibi T Ao Z-j Azizi H Mahmoudi M Coombs K Kobasa D Kobinger G Yao X-j 2021. Development and characterization of influenza M2 ectodomain and\/or HA stalk-based DC-targeting vaccines for different influenza infections. BioRxiv. 10.1101\/2021.10.07.463539.","DOI":"10.1101\/2021.10.07.463539"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2006.02.006"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4172"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.144.5.1808","article-title":"The human lung fibroblast cell line, MRC-5, produces multiple factors involved with megakaryocytopoiesis","volume":"144","author":"Yamamoto R","year":"1990","unstructured":"Yamamoto R, Lin LS, Lowe R, Warren MK, White TJ. 1990. The human lung fibroblast cell line, MRC-5, produces multiple factors involved with megakaryocytopoiesis. J Immunol 144:1808\u20131816.","journal-title":"J Immunol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2021.100929"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010022"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03777-9"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.751778"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13010109"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103530"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-02532-4"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103788"},{"key":"e_1_3_2_48_2","first-page":"2100640","article-title":"Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021","volume":"26","author":"de Gier B","year":"2021","unstructured":"de Gier B, Andeweg S, Joosten RT, Schegget R, Smorenburg N, van de Kassteele J, Hahn\u00e9 SJ, van den Hof S, de Melker HE, Knol MJ, members of the RIVM COVID-19 surveillance and epidemiology team. 2021. Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021. Euro Surveill 26:2100640.","journal-title":"Euro Surveill"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.07.22270437"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-01649-6"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2004.10.006"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir379"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw218"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00597-19"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2021.101495"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.706902"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0155-z"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1086\/520591"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2104.142012"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001567"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000225"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216949"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00044-21"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-62"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040389"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.07.006"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01337-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01337-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T10:24:20Z","timestamp":1676715860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.01337-22"}},"subtitle":[],"editor":[{"given":"Tom","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":66,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,9,28]]}},"alternative-id":["10.1128\/jvi.01337-22"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01337-22","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"2022-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01337-22"}}